Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy ; volume:73 ; number:9 ; day:2 ; month:7 ; year:2024 ; pages:1-14 ; date:9.2024
Cancer immunology immunotherapy ; 73, Heft 9 (2.7.2024), 1-14, 9.2024
- Creator
-
Zhang, Zongliang
Yang, Nian
Xu, Long
Lu, Huaqing
Chen, Yongdong
Wang, Zeng
Lu, Qizhong
Zhong, Kunhong
Zhu, Zhixiong
Wang, Guoqing
Li, Hexian
Zheng, Meijun
Zhou, Liangxue
Tong, Aiping
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-024-03757-8
- URN
-
urn:nbn:de:101:1-2410310823270.185058496362
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Zongliang
- Yang, Nian
- Xu, Long
- Lu, Huaqing
- Chen, Yongdong
- Wang, Zeng
- Lu, Qizhong
- Zhong, Kunhong
- Zhu, Zhixiong
- Wang, Guoqing
- Li, Hexian
- Zheng, Meijun
- Zhou, Liangxue
- Tong, Aiping
- SpringerLink (Online service)
Other Objects (12)
Oncolytic virotherapy of glioblastoma
A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Key parameters of measles virus production for oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Oncolytic virotherapy of glioblastoma
A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Key parameters of measles virus production for oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Oncolytic virotherapy of glioblastoma
A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Key parameters of measles virus production for oncolytic virotherapy